83 related articles for article (PubMed ID: 27249841)
1. Integrative Analysis of Proteomic, Glycomic, and Metabolomic Data for Biomarker Discovery.
Wang M; Yu G; Ressom HW
IEEE J Biomed Health Inform; 2016 Sep; 20(5):1225-1231. PubMed ID: 27249841
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of LC-MS based glycomic and proteomic data.
Wang M; Yu G; Ressom HW
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():8185-8. PubMed ID: 26738194
[TBL] [Abstract][Full Text] [Related]
3. Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies.
Wang M; Tsai TH; Di Poto C; Ferrarini A; Yu G; Ressom HW
BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):545. PubMed ID: 27535232
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis to select cancer candidate biomarkers to targeted validation.
Kawahara R; Meirelles GV; Heberle H; Domingues RR; Granato DC; Yokoo S; Canevarolo RR; Winck FV; Ribeiro AC; Brandão TB; Filgueiras PR; Cruz KS; Barbuto JA; Poppi RJ; Minghim R; Telles GP; Fonseca FP; Fox JW; Santos-Silva AR; Coletta RD; Sherman NE; Paes Leme AF
Oncotarget; 2015 Dec; 6(41):43635-52. PubMed ID: 26540631
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma.
Tsai TH; Song E; Zhu R; Di Poto C; Wang M; Luo Y; Varghese RS; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
Proteomics; 2015 Jul; 15(13):2369-81. PubMed ID: 25778709
[TBL] [Abstract][Full Text] [Related]
6. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
7. Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients.
Xue R; Dong L; Wu H; Liu T; Wang J; Shen X
Clin Chem Lab Med; 2009; 47(3):305-10. PubMed ID: 19676142
[TBL] [Abstract][Full Text] [Related]
8. Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.
Osman D; Ali O; Obada M; El-Mezayen H; El-Said H
Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 27862090
[TBL] [Abstract][Full Text] [Related]
9. The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
Wang H; Shi T; Qian WJ; Liu T; Kagan J; Srivastava S; Smith RD; Rodland KD; Camp DG
Expert Rev Proteomics; 2016; 13(1):99-114. PubMed ID: 26581546
[TBL] [Abstract][Full Text] [Related]
10. A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information.
Lin X; Yang F; Zhou L; Yin P; Kong H; Xing W; Lu X; Jia L; Wang Q; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 910():149-55. PubMed ID: 22682888
[TBL] [Abstract][Full Text] [Related]
11. Integrative system biology strategies for disease biomarker discovery.
Zhang H; Hu H; Deng C; Chun Y; Zhou S; Huang F; Zhou Q
Comb Chem High Throughput Screen; 2012 May; 15(4):286-98. PubMed ID: 22221061
[TBL] [Abstract][Full Text] [Related]
12. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
[TBL] [Abstract][Full Text] [Related]
13. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
[TBL] [Abstract][Full Text] [Related]
14. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
15. Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry.
Chen S; Kong H; Lu X; Li Y; Yin P; Zeng Z; Xu G
Anal Chem; 2013 Sep; 85(17):8326-33. PubMed ID: 23889541
[TBL] [Abstract][Full Text] [Related]
16. Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discovery.
McArdle A; Qasim Butt A; Szentpetery A; de Jager W; de Roock S; FitzGerald O; Pennington SR
Proteomics Clin Appl; 2016 Jun; 10(6):691-8. PubMed ID: 26332844
[TBL] [Abstract][Full Text] [Related]
17. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
18. Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples.
Fernández Del Río R; O'Hara ME; Holt A; Pemberton P; Shah T; Whitehouse T; Mayhew CA
EBioMedicine; 2015 Sep; 2(9):1243-50. PubMed ID: 26501124
[TBL] [Abstract][Full Text] [Related]
19. MassUntangler: a novel alignment tool for label-free liquid chromatography-mass spectrometry proteomic data.
Ballardini R; Benevento M; Arrigoni G; Pattini L; Roda A
J Chromatogr A; 2011 Dec; 1218(49):8859-68. PubMed ID: 21783198
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
